GTDataGroup LegalCore

Texas legal research

CP chapter 82

Sec. 82.007. MEDICINES.

Civil Practice and Remedies Code § 82.007

(a) In a products liability action alleging that an injury was caused by a failure to provide adequate warnings or information with regard to a pharmaceutical product, there is a rebuttable presumption that the defendant or defendants, including a health care provider, manufacturer, distributor, and prescriber, are not liable with respect to the allegations involving failure to provide adequate warnings or information if:

(1) the warnings or information that accompanied the product in its distribution were those approved by the United States Food and Drug Administration for a product approved under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 301 et seq.), as amended, or Section 351, Public Health Service Act (42 U.S.C. Section 262), as amended; or

(2) the warnings provided were those stated in monographs developed by the United States Food and Drug Administration for pharmaceutical products that may be distributed without an approved new drug application.

(b) The claimant may rebut the presumption in Subsection (a) as to each defendant by establishing that:

(1) the defendant, before or after pre-market approval or licensing of the product, withheld from or misrepresented to the United States Food and Drug Administration required information that was material and relevant to the performance of the product and was causally related to the claimant's injury;

(2) the pharmaceutical product was sold or prescribed in the United States by the defendant after the effective date of an order of the United States Food and Drug Administration to remove the product from the market or to withdraw its approval of the product;

(3)(A) the defendant recommended, promoted, or advertised the pharmaceutical product for an indication not approved by the United States Food and Drug Administration;

(B) the product was used as recommended, promoted, or advertised; and

(C) the claimant's injury was causally related to the recommended, promoted, or advertised use of the product;

(4)(A) the defendant prescribed the pharmaceutical product for an indication not approved by the United States Food and Drug Administration;

(B) the product was used as prescribed; and

(C) the claimant's injury was causally related to the prescribed use of the product; or

(5) the defendant, before or after pre-market approval or licensing of the product, engaged in conduct that would constitute a violation of 18 U.S.C. Section 201 and that conduct caused the warnings or instructions approved for the product by the United States Food and Drug Administration to be inadequate.

Added by Acts 2003, 78th Leg., ch. 204, Sec. 5.02, eff. Sept. 1, 2003.

Source details
canonical id
tx-statute:cp:82.007
provision id
tx-statute:cp:[email protected]
version id
tx-statute:cp:[email protected]~b8aad98217e6bc42
record id
tx-statute:cp:[email protected]
document id
tx-statute-chapter:cp:82
record sha256
9d5fca6329a0936d27cba228f9f359a2c30874947e155f515107da3981f7640c
anchor id
p-82-007-5516-4742
legalcore record url
https://legalcore.example.invalid/tx/statutes/cp/sections/82.007/5516.4742

Source locations are recorded for verification and are not links.

References in this section

  • Sec. 82.007. MEDICINES.
    Reference details
    original href
    https://statutes.capitol.texas.gov/Docs/CP/htm/CP.82.htm#82.007
    target fragment
    82.007
    source context
    paragraph
    resolution reason
    unique prepared provision #82.007 in tx-statute-chapter:cp:82
    expected target id
    tx-statute:cp:82.007
    source document id
    tx-statute-chapter:cp:82
    source provision id
    tx-statute:cp:[email protected]
    target document id
    tx-statute-chapter:cp:82
    target provision id
    tx-statute:cp:[email protected]
    target version id
    tx-statute:cp:[email protected]~b8aad98217e6bc42
    candidate
    tx-statute:cp:[email protected]
    resolution status
    resolved

    Source locations are recorded for verification and are not links.

Cited by

  • CP § 82.007 cites it as “Sec. 82.007. MEDICINES.”
    Reference details
    original href
    https://statutes.capitol.texas.gov/Docs/CP/htm/CP.82.htm#82.007
    target fragment
    82.007
    source context
    paragraph
    resolution reason
    unique prepared provision #82.007 in tx-statute-chapter:cp:82
    expected target id
    tx-statute:cp:82.007
    source document id
    tx-statute-chapter:cp:82
    source provision id
    tx-statute:cp:[email protected]
    target document id
    tx-statute-chapter:cp:82
    target provision id
    tx-statute:cp:[email protected]
    target version id
    tx-statute:cp:[email protected]~b8aad98217e6bc42
    candidate
    tx-statute:cp:[email protected]
    resolution status
    resolved

    Source locations are recorded for verification and are not links.

  • CP § 82.008 cites it as “82.007”
    Reference details
    original href
    https://statutes.capitol.texas.gov/GetStatute.aspx?Code=CP&Value=82.007
    target fragment
    82.007
    source context
    paragraph
    resolution reason
    unique prepared provision tx-statute:cp:82.007
    expected target id
    tx-statute:cp:82.007
    source document id
    tx-statute-chapter:cp:82
    source provision id
    tx-statute:cp:[email protected]
    target document id
    tx-statute-chapter:cp:82
    target provision id
    tx-statute:cp:[email protected]
    target version id
    tx-statute:cp:[email protected]~b8aad98217e6bc42
    candidate
    tx-statute:cp:[email protected]
    resolution status
    resolved

    Source locations are recorded for verification and are not links.

Citations show recorded connections only, not legal effect or validity.